Theravance Biopharma Inc Cash Flow Reinvestment Rate
Latest as of June 2025:
0.17x
Theravance Biopharma Inc cash flow reinvestment rate. Theravance Biopharma Inc (0TB) has a Cash Flow Reinvestment Rate of 0.17x as of June 2025, reinvesting €36.22 Million (capex €0.00 plus investments €-36.22 Million) from operating cash flow of €208.07 Million. Explore Theravance Biopharma Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.17x
(Capex + Investments) / Operating CF
Total Reinvested
€36.22 Million
Capex + Investments
Operating Cash Flow
€208.07 Million
EUR
Capital Expenditures
€0.00
EUR
Theravance Biopharma Inc Cash Flow Reinvestment Rate by Year (None–None)
Theravance Biopharma Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Theravance Biopharma Inc. For the full cash flow conversion analysis, see 0TB cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow